Robert Daniel

City MD expansion proceeds well, entails risks: S&P

Israeli high-tech fundings rack up over $1 bln in Q1 '17, says new report

Israel’s high-tech companies raised a total of $1.03 billion in Q1 2017, an 8 percent decline from the year-earlier period and a 4 percent drop from Q4 2016, according to a report from IVC Research Center, the trade group and law firm Zysman, Aharoni, Gayer & Co. The report also noted that the first-quarter financings were made in 155 deals, which is down 11 percent from a year earlier.

Leveraged Loans: S&P cuts rating at Catterton's Ferrara Candy

TPG-backed Immucor outlook cut to negative at S&P on refinance concern

PE-backed Foresight Energy debt revamp prompts S&P to lift outlook

PaperWorks, backed by Sun Capital, weighed down by leverage: Moody's

PE-backed Payless is seen restructuring debt within a year: S&P

Copia targets $50 mln for new Israeli agro/food tech fund

Copia Agro & Food, a Tel Aviv fund focused on agriculture and food products, is raising $50 million for investment in Israeli technologies addressing issues including climate change and food shortages. Managing the fund will be Ohad Zuckerman, former CEO of Zeraim Gedera and Eyal Cohen, managing partner at Copia.

VC-backed Gamida Cell adds Adams to board

Gamida Cell, a Jerusalem-based developer of cellular and immune therapies that treat cancer and genetic diseases, has named Dr. Julian Adams as chairman of its board of directors. Adams, who succeeds Ruben Krupik as Gamida's chairman, is president of R&D at Infinity Pharmaceuticals. Gamida is backed by investment firms including Israel Healthcare Ventures, Denali Ventures and Auriga Ventures.

Missouri and Israel seal co-investment pact to develop tech jobs

Missouri and Israel signed a co-investment agreement, designed to develop projects and create jobs. Missouri Gov. Jay Nixon and Israel Chief Scientist Avi Hasson said in a Nov. 17 joint statement that the accord creates a framework through which for-profit companies in the state and nation can develop and commercialize technologies in aerospace and defense, cybersecurity, biotechnology and agriculture.